Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management (original) (raw)
Management of Cancer Treatment–Related Diarrhea
Hillard M Lazarus
Journal of Pain and Symptom Management, 2000
View PDFchevron_right
Management of acute cancer treatment-induced diarrhea
Cindy Ippoliti
Seminars in Oncology Nursing, 2003
View PDFchevron_right
Anti-Colorectal Cancer Chemotherapy-Induced Diarrhoea: Current Treatments and Side-Effects
Joel Bornstein
International Journal of Clinical Medicine, 2014
View PDFchevron_right
Evaluation and validation of chemotherapy‐specific diarrhoea and histopathology in rats
Fredrik Kullenberg
Basic & Clinical Pharmacology & Toxicology
View PDFchevron_right
Chemotherapy-induced diarrhoea
Andrea Stringer
Current Opinion in Supportive and Palliative Care, 2009
View PDFchevron_right
Evaluation and Management of Treatment-Related Diarrhea in Patients with Advanced Cancer: A Review
Nathan Cherny
Journal of Pain and Symptom Management, 2008
View PDFchevron_right
Octreotide in the treatment of severe chemotherapy-induced diarrhea
A Beny
2016
View PDFchevron_right
Preliminary Study for Development of an Experimental Model of Cancer Chemotherapy Induced Diarrhea
kaumudee pattnaik
International Journal of Contemporary Medical Research [IJCMR], 2020
View PDFchevron_right
New strategies for the prevention and reduction of cancer treatment-induced diarrhea
Lowell Anthony
Seminars in Oncology Nursing, 2003
View PDFchevron_right
Risk and outcomes of chemotherapy-induced diarrhea (CID) among patients with colorectal cancer receiving multi-cycle chemotherapy
Giuseppe Aprile
Cancer Chemotherapy and Pharmacology, 2014
View PDFchevron_right
Cancer chemotherapy-induced diarrhoea and constipation: mechanisms of damage and prevention strategies
Rachel Gibson
Supportive Care in Cancer, 2006
View PDFchevron_right
Distinct diarrhea profiles during outpatient chemotherapy
Marilyn Hammer
Supportive Care in Cancer, 2020
View PDFchevron_right
Biweekly Administration of Irinotecan (CPT-11) Plus Cisplatin with an Antidiarrheal Program of Intestinal Alkalization to Reduce Diarrhea in Cancer Patients
Kunihiko Kobayashi
Annals of Cancer Research and Therapy, 2012
View PDFchevron_right
Elsiglutide in the primary prevention of chemotherapy (CT)-induced diarrhea in patients with colorectal cancer (CRC) receiving 5-fluorouracil (5-FU)-based CT: A multinational, randomized, double-blind, placebo-controlled study
Riccardo Spezia
Journal of Clinical Oncology, 2017
View PDFchevron_right
Randomized trial of loperamide versus dose escalation of octreotide acetate for chemotherapy-induced diarrhea in bone marrow transplant and leukemia patients
John Wingard
American Journal of Hematology, 1995
View PDFchevron_right
Octreotide (SMS 201–995) for hematopoietic support-dependent high-dose chemotherapy (HSD-HDC)-related diarrhoea: dose finding study and evaluation of efficacy
H. Cortés-funes
Bone Marrow Transplantation, 1997
View PDFchevron_right
Randomized Phase III Trial Exploring the Use of Long-Acting Release Octreotide in the Prevention of Chemotherapy-Induced Diarrhea in Patients With Colorectal Cancer: The LARCID Trial
Renata Chinen
Journal of Clinical Oncology, 2014
View PDFchevron_right
Chemotherapy-induced diarrhea is associated with changes in the luminal environment in the DA rat
Andrea Stringer
Experimental biology and medicine (Maywood, N.J.), 2007
View PDFchevron_right
Incidence and relative risk of grade 3 and 4 diarrhoea in patients treated with capecitabine or 5-fluorouracil: a meta-analysis of published trials
Roberto Iacovelli
British Journal of Clinical Pharmacology, 2014
View PDFchevron_right
Severe chemotherapy-induced diarrhea in patients with colorectal cancer: a cost of illness analysis
Amil Shah
Supportive Care in Cancer, 2005
View PDFchevron_right
Acute diarrhea during adjuvant therapy for rectal cancer: a detailed analysis from a randomized intergroup trial
Robert Mayer
International Journal of Radiation Oncology*Biology*Physics, 2002
View PDFchevron_right
Modulation of Irinotecan-induced Diarrhea by Cotreatment with Neomycin in Cancer Patients1
Diederik Kehrer
2001
View PDFchevron_right
Acute treatment-related diarrhea during postoperative adjuvant therapy for high-risk rectal carcinoma
Daniel Sargent
International Journal of Radiation Oncology*Biology*Physics, 1998
View PDFchevron_right
Severe enteropathy among patients with stage II/III colon cancer treated on a randomized trial of bolus 5-fluorouracil/leucovorin plus or minus oxaliplatin: A prospective analysis
Bridget Robinson
Cancer, 2007
View PDFchevron_right
New approaches to prevent intestinal toxicity of irinotecan-based regimens
Debora Rasio
Cancer treatment …, 2004
View PDFchevron_right
Modulation of irinotecan-induced diarrhea by cotreatment with neomycin in cancer patients
Diederik Kehrer
2001
View PDFchevron_right
Spectrum of Drug-induced Chronic Diarrhea
Nazir Ahmed
Journal of Clinical Gastroenterology, 2017
View PDFchevron_right
Unanticipated frequency and consequences of regimen-related diarrhea in patients being treated with radiation or chemoradiation regimens for cancers of the head and neck or lung
Pamela Randolph-Jackson
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2015
View PDFchevron_right
Severe diarrhea in patients with advanced-stage colorectal cancer receiving FOLFOX or FOLFIRI chemotherapy: the development of a risk prediction tool
Amil Shah
Clinical colorectal cancer, 2007
View PDFchevron_right
Prevention of irinotecan induced diarrhea by probiotics. A randomized double blind, placebo controlled pilot study
Michal Mego, Lubos Drgona
Complementary Therapies in Medicine, 2015
View PDFchevron_right